Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders

Medical Hypotheses

Volumn 55, Issue 3, 2000, Pages 199-207

  Bersani, G ^a   Iannitelli, A ^a   Fiore, M ^b,c   Angelucci, F ^b,d   Aloe, L ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; HALOPERIDOL; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4;

BEHAVIOR; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE CELL; FOREBRAIN; HUMAN; MENTAL DISEASE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEIZURE; STRESS;

EID: 0033801746     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.1044     Document Type: Article

References (111)

1. The nerve growth factor 35 years later
2. A role of nerve growth factor in nervous, endocrine and immune systems
3. Distribution and retrograde transport of trophic factor in the central nervous system: Functional implications for the treatment of neurodegenerative diseases
4. Neurotrophin receptor: Mediators of life and death
5. Neurotrophins and synaptic plasticity
6. Roles of neurotrophins on synaptic development and functions in the central nervous system
7. Selective growth-stimulation effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo
8. Effects of mouse tumor transplants on nervous system
9. A diffusible agent of mouse sarcoma producing hyperplasia of sympathetic ganglia and hyperneurotization of viscera in the chick embryo
10. In vitro experiments on the effects of mouse sarcomas 180 and 37 on the spinal and sympathetic ganglia of the chick embryo
11. A nerve growth stimulating factor isolated from sarcoma 37 and 180
12. Purification and metabolic effects of a nerve growth-promoting protein from snake venom
13. Purification of a nerve-growth promoting protein from the mouse salivary gland and its neurocytotoxic antiserum
14. The physiological function of nerve growth factor in the central nervous system: Comparison with the periphery
15. Nerve growth factor prevents toxic neuropathy in mice
16. Therapeutic potential of neurotrophic factors for neurological disorders
17. Neurotrophins: The biological paradox of survival factors eliciting apoptosis
18. The nerve growth factor family
19. Brain-derived neurotrophic factor is more highly conserved in structure and function than nerve growth factor during vertebrate evolution
20. The isolation of the mouse nerve growth factor protein in a high molecular weight form
21. The nerve growth factor: Purification as a 30.000-molecular-weight protein
22. Nerve growth factor
23. Nerve growth factor and related substance: Structure and mechanisms of action
24. NGF in CNS: Experimental data and clinical implications
25. The physiological function of nerve growth factor in the central nervous system: Comparison with the periphery
26. The expression, localization and functional significance of β-nerve growth factor in the central nervous system
27. Nerve growth factor and autoimmune diseases
28. NGF is released into plasma during human pregnancy: An oxytocin-mediated response?
29. Stimulation of the pituitary-adrenocortical axis by nerve growth factor
30. Development of effective therapy for Alzheimer's disease based on neurotrophic factors
31. Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases
32. Topical treatment with nerve growth factor for corneal neurotrophic ulcers
33. Limbic seizures increase neuronal production of messenger RNA for nerve growth factor
34. The NGF-B gene, a transcriptionally inducible member of the steroid receptor gene superfamily: Genomic structure and expression in rat brain after seizure induction
35. NGFI-C expression is affected by physiological stimulation and seizures in the somatosensory cortex
36. Kainic acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus
37. Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures
38. Regulation of nerve growth factor mRNA in the hippocampal formation: Effects of N-Methyl-D-Aspartate receptor activation
39. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNAs in adult rat brain after intrahippocampal injection of quinolinic acid
40. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: Temporal patterns of induction distinct from NGF
41. Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3, in the rat hippocampus
42. Seizure-induced increases in NGF mRNA exhibit different time courses across forebrain regions and are biphasic in hippocampus
43. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis
44. Regulation of neurotrophin and trkA, trkB and trkC tyrosine Kinase receptor messenger RNA expression in kindling
45. Regional increases in brain-derived neurotrophic factor and nerve growth factor mRNAs during amygdaloid kindling, but not in acidic and basic fibroblast growth factor mRNAs
46. Regional and temporal pattern of expression of nerve growth factor and basic fibroblast growth factor mRNA in rat brain following electroconvulsive shock
47. H. Selective inhibition of axon outgrowth by antibodies to NGF in a model of temporal lobe epilepsy
48. Mossy fiber synaptic reorganization in the epileptic human temporal lobe
49. A neuroendocrine theory of convulsive therapy
50. Seizure-induced serum NGF levels increase after ECT in psychiatric patients: A first pilot study in man
51. NGF plasma levels in psychiatric patients treated with ECT: Results at IV and VIII ECT
52. Electroconvulsive therapy (ECT) as stress, increases nerve growth factor (NGF) plasma levels in psychiatric patients
53. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream
54. Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression
55. Social status and nerve growth factor serum levels after agonistic encounters in mice
56. Nerve growth factor into the bloodstream following intraspecific fighting induces mast cell degranulation in adult male mice
57. NGF decreases isolation-induced aggressive behavior, while increasing adrenal volume, in adult male mice
58. Physiological roles of nerve growth factor in adult rodents: A biobehavioral perspective
59. An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates
60. Mental stress and adrenaline increase plasma growth factor activity in humans
61. Physical exercise induces FGF-2 and its mRNA in the hippocampus
62. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain
63. Nerve growth factor-like activity detected in equine peripheral blood after running exercise
64. Neuro-behavioral alterations on developing transgenic mice expressing TNF-α in the brain
65. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes
66. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers
67. Aggressive behaviour induced by social isolation
68. The 'isolation syndrome' in mice
69. The effect of chronic ethanol intake on brain NGF level and on NGF-target tissues of adult mice
70. Prenatal haloperidol treatment decreases nerve growth factor receptor and mRNA in neonate rat forebrain
71. Haloperidol treatment decreases nerve growth factor levels in the hypothalamus of adult mice
72. Haloperidol administration in humans lowers plasma nerve growth factor level: Evidence that sedation induces opposed effect of arousal
73. HPA axis dysfunction in depression: Correlation with monoamine system abnormalities
74. Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation
75. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression
76. Neurotrophins and depression
77. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study
78. The genetics of schizophrenia is the genetics of neurodevelopment
79. Schizophrenia: From neuropathology to neurodevelopment
80. Cortical maldevelopment, schizophrenia, and antipsychotic drugs: A search for common ground
81. Le anomalie del lobo temporale nella schizofrenia negli studi di risonanza magnetica nucleare
82. Il corpo calloso nella schizofrenia negli studi di risonanza magnetica nucleare
83. Schizophrenia
84. Maternal influenza, obstetric complications, and schizophrenia
85. Schizophrenia: A neuronal diathesis-stress model
86. Schizophrenia as a neurodevelopmental disorder
87. Neurobiologic antecedents of schizophrenia in children: Evidence for an inherited, congenital neurointegrative defect
88. Schizophrenia following pre-natal exposure to influenza epidemics between 1939 and 1960
89. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens
90. Prenatal development of monozygotic twins and concordance for schizophrenia
91. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
92. Prenatal alcohol exposure and long-term developmental consequences
93. Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging
94. Neuronal growth factors, neurotrophins and memory deficiency
95. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity
96. Nerve Growth Factor increases choline acetyltransferase activity in developing basal forebrain neurons
97. Neuropsicologia delle sindromo schizofreniche
98. Schizophrenia as a developmental disorder of the cerebral cortex
99. Low nerve growth factor plasma levels in schizophrenic patients: A preliminary study
100. A turning point in schizophrenia genetics
101. Functional brain imaging and the neuropathology of schizophrenia
102. NT3, BDNF and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression
103. Neurotrophin-3 gene polymorphism associated with schizophrenia
104. Association of neurotrophin-3 gene variant with severe forms of schizophrenia
105. Schizophrenic psychoses and the CNTF null mutation
106. Initial studies of embryonic transplants of human hippocampus and cerebral cortex derived from schizophrenic women
107. Neuronal development in embryonic brain tissue derived from schizophrenic women and grafted to animal hosts
108. Methylazoxymethanol acetate-induced abnormalities in the entorhinal cortex of the rat; parallels with morphological findings in schizophrenia
109. Prenatal methylazoxymethanol acetate alters behavior and brain NGF levels in young rats: A possible correlation with the development of schizophrenia-like deficits
110. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia